| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |